CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-08-12 | BAKER BROS. ADVISORS LP 10% owner | Sale | −465,439 | $5.00 | $2.3M | 1,656,688 |
| 2016-08-12 | BAKER BROS. ADVISORS LP 10% owner | Sale | −2,834,561 | $5.00 | $14.2M | 10,059,679 |
| 2016-08-12 | BAKER BROS. ADVISORS LP 10% owner | Sale | −48,744 | $5.25 | $256K | 1,607,944 |
| 2016-08-12 | BAKER BROS. ADVISORS LP 10% owner | Sale | −296,856 | $5.25 | $1.6M | 9,762,823 |
| 2016-08-12 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −4,558 | $5.22 | $24K | 124,187 |
| 2016-08-11 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −1,306 | $5.05 | $7K | 128,745 |
| 2016-08-09 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −14,577 | $4.43 | $65K | 130,051 |
| 2016-05-31 | Hutson Nancy J Director | Grant or award | +2,581 | $3.39 | $9K | 24,443 |
| 2016-05-31 | Cohen Fred E Director | Grant or award | +2,581 | $3.39 | $9K | 111,646 |
| 2016-05-23 | Powell Lynne Senior VP - CCO | Grant or award · Emp. Stock Option (Right to Buy) | +129,427 | 129,427 | ||
| 2016-05-23 | Barnes Alane P VP, General Counsel & Corp Sec | Grant or award · Emp. Stock Option (Right to Buy) | +91,004 | 91,004 | ||
| 2016-05-23 | Babu Yarlagadda S Senior VP - Drug Discovery | Grant or award · Emp. Stock Option (Right to Buy) | +129,427 | 129,427 | ||
| 2016-05-23 | Sheridan William P Senior VP - CMO | Grant or award · Emp. Stock Option (Right to Buy) | +148,302 | 148,302 | ||
| 2016-05-23 | STAAB THOMAS R II Senior Vice President and CFO | Grant or award · Emp. Stock Option (Right to Buy) | +129,427 | 129,427 | ||
| 2016-05-23 | Stonehouse Jon P President & CEO | Grant or award · Emp. Stock Option (Right to Buy) | +337,050 | 337,050 | ||
| 2016-05-23 | Patel Sanj K Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2016-05-23 | LEE KENNETH B JR Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2016-05-23 | INGRAM ROBERT ALEXANDER Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2016-05-23 | Hutson Nancy J Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2016-05-23 | Erck Stanley C Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 |
Page 43 of 45 · 882 trades